Amnestic and non‐amnestic symptoms of dementia: An international study of Alzheimer's disease in people with Down's syndrome
Luciana M. Fonseca,Concepcion Padilla,Elizabeth Jones,Natalie Neale,Glenda G. Haddad,Guilherme P. Mattar,Eriton Barros,Isabel C. H. Clare,Geraldo F. Busatto,Cassio M. C. Bottino,Marcelo Q. Hoexter,Anthony J. Holland,Shahid Zaman
DOI: https://doi.org/10.1002/gps.5283
2020-03-15
International Journal of Geriatric Psychiatry
Abstract:<section class="article-section__content"><p>The presence of age‐related neuropathology characteristic of Alzheimer‧s disease (AD) in people with Down syndrome (DS) is well‐established. However, the early symptoms of dementia may be atypical and appear related to dysfunction of pre‐frontal circuitry.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Objective</h3><p>To characterize the initial informant reported age‐related neuropsychiatric symptoms of dementia in people with DS and their relationship to AD and frontal lobe function.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Methods</h3><p>Non‐amnestic informant reported symptoms (disinhibition, apathy and executive dysfunction) and amnestic symptoms from the CAMDEX‐DS informant interview were analysed in a cross‐sectional cohort of 162 participants with DS over 30 years of age, divided into three groups: stable cognition, prodromal dementia, and AD. To investigate age‐related symptoms prior to evidence of prodromal dementia we stratified the stable cognition group by age.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Results</h3><p>Amnestic and non‐amnestic symptoms were present before evidence of informant‐reported cognitive decline. In those who received the diagnosis of AD, symptoms tended to be more marked. Memory impairments were more marked in the prodromal dementia than the stable cognition group (OR=35.07; <i>P</i><0.001), as was executive dysfunction (OR=7.16; <i>P</i><0.001). Disinhibition was greater in the AD than in the prodromal dementia group (OR=3.54; <i>P</i>=0.04). Apathy was more pronounced in the AD than in the stable cognition group (OR=34.18; <i>P</i><0.001). </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Conclusion</h3><p>Pre‐morbid amnestic and non‐amnestic symptoms as reported by informants increase with the progression to AD. For the formal diagnosis of AD in DS this progression of symptoms needs to be taken into account. An understanding of the unique clinical presentation of DS in AD should inform treatment options.</p><p>This article is protected by copyright. All rights reserved.</p></section>
psychiatry,geriatrics & gerontology,gerontology